HDAC9 and Alzheimer disease: The HDAC inhibitor, W2, improved performance in the Morris water maze, decreased amyloid-β levels, and also increased expression of the amyloid-β degrading enzyme MMP2 in 3xTg AD mice (Sung et al., 2013).